Dodecanoic acid - CAS 143-07-7

Catalog:	BB009492
Product Name:	Dodecanoic acid
CAS:	143-07-7
Synonyms:	Lauric Acid; Dodecoic acid; Duodecylic acid; 1-Dodecanoic Acid; 1-Undecanecarboxylic Acid; ABL; ContraZeck; Laurostearic Acid; NSC 5026; Vulvic Acid; N-Dodecanoic Acid
Application:	Ingredient of health care products.

Technical Data

IUPAC Name:	dodecanoic acid
Description:	Lauric acid is a saturated fatty acid, which is found in animal and plant fats and oils, and is a major component of coconut oil and palm kernel oil. It has potential antimicrobial property, and can be used in soaps and shampoos manufacturing. Nutritional supplement in health care products.
Molecular Weight:	200.32
Molecular Formula:	C12H24O2
Canonical SMILES:	CCCCCCCCCCCC(=O)O
InChI:	InChI=1S/C12H24O2/c1-2-3-4-5-6-7-8-9-10-11-12(13)14/h2-11H2,1H3,(H,13,14)
InChI Key:	POULHZVOKOAJMA-UHFFFAOYSA-N
Boiling Point:	296.1±3.0°C at 760 mmHg
Melting Point:	46-47°C
Flash Point:	156°C
Purity:	98%
Density:	0.883 g/mL at 25°C
Solubility:	Soluble in DMSO (Slightly), Methanol (Slightly)
Appearance:	White solid
Storage:	Store at RT
Decomposition:	When heated to decomp it emits acrid smoke and fumes
MDL:	MFCD00002736
LogP:	3.99190
Refractive Index:	1.4304
Stability:	Stable. Combustible. Incompatible with bases, oxidizing agents, reducing agents.
Vapor Pressure:	1 mm Hg ( 121 °C)

GHS Hazard Statement:	H315 (14.66%): Causes skin irritation [Warning Skin corrosion/irritation]
Precautionary Statement:	P264, P280, P302+P352, P305+P351+P338, P310, P321, P332+P313, P337+P313, and P362
Signal Word:	Danger

Publication Number	Title	Priority Date
EP-3818972-A2	Piroctone olamine granules for use in cosmetic compositions	20210129
US-10981872-B1	Di(2-aryl hydrozonopropanal) arene derivatives	20201027
US-11000534-B1	Deuterated derivatives of psilocybin and uses thereof	20201008
US-2021007978-A1	Fixed Dose Oral Testosterone Undecanoate Compositions and Use Thereof	20200925
US-10975102-B1	Heterocyclic diazenyl pyridinone copper(II) complexes as pharmacological antitumor agents	20200921

PMID	Publication Date	Title	Journal
34506767	20211001	Lauric acid alleviates deoxynivalenol-induced intestinal stem cell damage by potentiating the Akt/mTORC1/S6K1 signaling axis	Chemico-biological interactions
33581636	20210415	Developmental exposures to perfluorooctanesulfonic acid (PFOS) impact embryonic nutrition, pancreatic morphology, and adiposity in the zebrafish, Danio rerio	Environmental pollution (Barking, Essex : 1987)
32320717	20200601	Piperonyl butoxide: Mode of action analysis for mouse liver tumour formation and human relevance	Toxicology
31721581	20200312	An Agonist Radioligand for the Proinflammatory Lipid-Activated G Protein-Coupled Receptor GPR84 Providing Structural Insights	Journal of medicinal chemistry
29976573	20180901	A Specific Probe Substrate for Evaluation of CYP4A11 Activity in Human Tissue Microsomes and a Highly Selective CYP4A11 Inhibitor: Luciferin-4A and Epalrestat	The Journal of pharmacology and experimental therapeutics

Complexity:	132
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	1
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	200.177630004
Formal Charge:	0
Heavy Atom Count:	14
Hydrogen Bond Acceptor Count:	2
Hydrogen Bond Donor Count:	1
Isotope Atom Count:	0
Monoisotopic Mass:	200.177630004
Rotatable Bond Count:	10
Topological Polar Surface Area:	37.3 Å²
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0
XLogP3:	4.2